< Back to news
Groupe Berkem announces the strategic acquisition of i.Bioceuticals
- Establishment of Groupe Berkem in North America
- Expansion of the Group’s bio-based offer in the very promising Nutraceuticals market
- Integration of an immediately accretive acquisition as of today
Blanquefort (France), 16 February 2023, at 6:00pm – Groupe Berkem (the “Group”), a leading player in bio-based chemicals (ISIN code: FR00140069V2 – Ticker: ALKEM), announced today the closing of the acquisition of i.Bioceuticals, Inc., the leading and exclusive North American distributor of nutritional ingredients from the Dutch company INC (International Nutrition Company), from INC.